Services
LWC has experience working in the following therapeutic areas: oncology, pulmonology, allergy, rheumatology, psychiatry, cardiology, and endocrinology. Major clients include a variety of groups within the following companies: GlaxoSmithKline, AstraZeneca, Eli Lilly & Co, Biogen Idec, Actelion and Novartis.

1. Health Outcomes Support
2. Pharmaco-epidemiology, Safety and Risk Management
3. Early Development Support
4. Brand Support
5. Delivery

Health Outcomes Support
Epidemiology and burden of disease assessment using literature or databases to understand disease, patient segments, hospital admission and mortality rates in populations from global and international markets. Statistical models can be provided of risk rates, time to event, and total cost burden.

Pharmaco-epidemiology, Safety and Risk Management
Assessment of:

• Drug exposure at population level using longitudinal and cross sectional data.
• Safety signals.
• Potential risk/benefit from drug exposure in target populations.
• Contribution to benefit risk plans and management.

Early Development Support

• Potential target population evaluation in terms of disease rates, co-morbidities, current drug use and patient outcome.
• Observational studies to detect potential therapeutic signals in new populations for secondary indications.

Brand Support
To aid in market penetration and brand growth LWC can perform global and local studies to report drug uptake, competitor drug use, and patient outcome. LWC works with key opinion leaders to publish material to gain leverage in the market place.

Delivery
LWC offers timely delivery of:

• Analyses – performed in US, European and UK databases.
• Literature reviews.
• Positioning papers
• Manuscripts and abstracts.
• Conference materials.
• Reports.
• Powerpoint presentations.
• KOL identification and liaison.